DIRECTORS AND SENIOR MANAGEMENT

Executive Director

Mr. John V. Oyler, aged 50, is our Co-Founder, Chief Executive Officer and Chairman of our
Board. He has served as a member of our Board since October 2010. From 2005 to 2009, Mr. Oyler
served as President and Chief Executive Officer of BioDuro, LLC, a drug discovery outsourcing
company, which was acquired by Pharmaceutical Product Development Inc. From 2002 to 2004, Mr.
Oyler served as Chief Executive Officer of Galenea Corp., a biopharmaceutical company dedicated to
the discovery of novel therapies for central nervous system diseases, which initially were developed
at Massachusetts Institute of Technology. From 1998 to 2002, Mr. Oyler was a Founder and the
President of Telephia, Inc. which was bought by The Nielsen Company in 2007. From 1997 to 1998,
Mr. Oyler served as Co-Chief Executive Officer of Genta Incorporated, an oncology-focused
biopharmaceutical company listed on the Nasdaq under ticker symbol “GNTA”. Mr. Oyler began his
career as a management consultant at McKinsey & Company.

Mr. Oyler received his B.S. from the Massachusetts Institute of Technology in June, 1990 and

an MBA from Stanford University in January, 1996.

Non-Executive Director

Dr. Xiaodong Wang, Ph.D., aged 55, is our Co-Founder and has served as a member of our Board
since February 2016. He has also served as the Chairman of our Scientific Advisory Board since 2011.
Dr. Wang has served as the founding Director of the National Institute of Biological Sciences in
Beijing since 2003 and became its Director and Investigator in 2010. Previously, he was a Howard
Hughes Medical Institute Investigator from 1997 to 2010 and held the position of the George L.
MacGregor Distinguished Chair Professor
the University of Texas
Southwestern Medical Center in Dallas, Texas from 2001 to 2010. In 2004, Dr. Wang founded Joyant
Pharmaceuticals, Inc., a venture capital-backed biotechnology company focused on the development
of small molecule therapeutics for cancer.

in Biomedical Sciences at

Dr. Wang received his B.S. in Biology from Beijing Normal University in July, 1984 and his
Ph.D. in Biochemistry from the University of Texas Southwestern Medical Center in May, 1991. Dr.
Wang has been a member of the National Academy of Science, USA since 2004 and a foreign associate
of the Chinese Academy of Sciences since 2013.

Independent Non-Executive Directors

Mr. Timothy Chen, aged 61, has served as a member of our Board since February 2016. Since
January 2018, Mr. Chen has served as the Chairman of Foxconn Industrial Internet Company, a
company listed on the Shanghai Stock Exchange since June 2018. From January 2016 to March 2018,
he served as the President and Chief Executive Officer of Asia Pacific Telecom and as the Corporate
Vice President of Hon Hai Technology Group. He served as the President of Telstra International
Group and Advisor to Telstra Chief Executive Officer from November 2012 to December 2015. He was
also the Chairman of Autohome, a company listed on the Nasdaq and a director of Qingdao Haier Co.,
Ltd., a company listed on the Shanghai Stock Exchange. He was a Non-Executive Director on the
Board of Telstra Corporation Limited, a company listed on the Australian Securities Exchange
between April 2012 and November 2012. Previously, Mr. Chen was a partner of a China Opportunities

— 323 —

